Proof of hydroxychloroquine’s efficacy to be available in July
Proof of whether hydroxychloroquine (HCQ), the controversial anti-malarial drug, can stave off COVID-19 infection will be available by July, a senior scientist of the Indian Council of Medical Research (ICMR), leading a large trial of the drug in healthcare workers, told The Hindu. In the largest Indian study of its kind, 2,000 doctors, nurses, paramedical workers, lab technicians and sanitary workers at five Indian hospitals are part of this trial, which began in May. The aim of the observational study is to check if at all, and to what extent, a regimen of HCQ will shield these healthcare workers, who work in dedicated COVID-19 hospitals — and therefore at high risk of contracting the novel coronavirus.
Read more top National stories on Crisp